Novavax stock skyrocketed

11:51 12 May 2020
Novavax (NVAX.US) shares soared 37% in extended trading after the company announced in its first-quarter report an external investment of $388 million which aims to advance the clinical development of its coronavirus vaccine.
Novavax (NVAX.US) shares have added about 370.6% since the beginning of the year. Source: xStation5 

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Back

Join over 1.6 Million investors from around the world